2020
DOI: 10.1177/1358863x20977016
|View full text |Cite
|
Sign up to set email alerts
|

Assessing health-related quality of life among patients with peripheral artery disease: A review of the literature and focus on patient-reported outcome measures

Abstract: Peripheral artery disease (PAD) is a progressive atherosclerotic disease associated with high rates of morbidity and mortality. Symptomatic PAD typically presents with claudication, and symptom severity strongly associates with reduced health-related quality of life (HRQoL). Existing treatment strategies for PAD are aimed at reducing symptom severity and improving functional outcomes. However, there is a need to incorporate patient-reported outcome measures (PROMs) into PAD treatment and research in order to p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(9 citation statements)
references
References 78 publications
0
9
0
Order By: Relevance
“…While the observed effect sizes were generally small to moderate, these exploratory findings might still be related to important treatment differentials that were not evident when assessed by objective walking tests such as maximal- and pain-free walking distance as reported in the primary analysis of the SUNFIT trial [ 12 ]. By integrating PROMs in clinical trials, a better understanding of patient- and treatment-related factors associated with improved or deteriorated health status over time can be achieved [ 29 ]. Therefore, our findings may provide an example of the importance of integrating PROMs alongside objective endpoints in clinical trials.…”
Section: Discussionmentioning
confidence: 99%
“…While the observed effect sizes were generally small to moderate, these exploratory findings might still be related to important treatment differentials that were not evident when assessed by objective walking tests such as maximal- and pain-free walking distance as reported in the primary analysis of the SUNFIT trial [ 12 ]. By integrating PROMs in clinical trials, a better understanding of patient- and treatment-related factors associated with improved or deteriorated health status over time can be achieved [ 29 ]. Therefore, our findings may provide an example of the importance of integrating PROMs alongside objective endpoints in clinical trials.…”
Section: Discussionmentioning
confidence: 99%
“…IC is strongly associated with reduced QoL, 33 however only one study 21 in this review investigated the impact on QoL as a consequence of exercise prescribed at different pain thresholds. Exercise prescribed to moderate claudication pain led to improvements in the physical component summary of the SF-36, and several single domains including physical functioning and bodily pain, whilst pain-free exercise led to improvements in the single domains of role physical and bodily pain.…”
Section: Qolmentioning
confidence: 99%
“…The main symptom of PAD is intermittent claudication, characterized by pain, cramp, or burning that occurs in the lower limbs during walking exercise and is relieved by rest [2]. Due to these symptoms, patients with PAD experience lower physical function [3], impaired cardiovascular function [4,5] and lower quality of life [6]. Based on evidence demonstrating the benefits of exercise on walking capacity [7], cardiovascular function [5,8] and quality of life [7], supervised exercise training is recommended in the United Kingdom by the National Institute for Health and Clinical Excellence as first-line treatment of claudication caused by PAD [9].…”
Section: Introductionmentioning
confidence: 99%